| Title | Cancer Biomarkers |
| Abbreviation | Cancer Biomark. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Oncology (Q3) |
| h-index | 57 |
| Overall Rank/Ranking | 9903 |
| SCImago Journal Rank (SJR) | 0.586 |
| Impact Score | 1.79 |
| Publisher | SAGE Publications Ltd |
| Country | Netherlands |
| ISSN | 15740153, 18758592 |
| Best Quartile | Q2 |
| Coverage History | 2005-2024 |
Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.
Cancer Biomarkers is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Oncology (Q3). It is published by SAGE Publications Ltd. The overall rank of Cancer Biomarkers is 9903. According to SCImago Journal Rank (SJR), this journal is ranked 0.586. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 57. The best quartile for this journal is Q2.
The ISSN of Cancer Biomarkers journal is 15740153, 18758592. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Biomarkers is cited by a total of 741 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Cancer Biomarkers is 1.79, which is computed in 2025 as per its definition. Cancer Biomarkers IF is decreased by a factor of 0.34 and approximate percentage change is -15.96% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Cancer Biomarkers is 1.79. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.79 |
| 2023 | 2.13 |
| 2022 | 2.86 |
| 2021 | 3.55 |
| 2020 | 3.83 |
| 2019 | 3.08 |
| 2018 | 2.70 |
| 2017 | 2.54 |
| 2016 | 2.40 |
| 2015 | 1.89 |
| 2014 | 1.87 |
Cancer Biomarkers has an h-index of 57. It means 57 articles of this journal have more than 57 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Biomarkers is 15740153, 18758592. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Biomarkers is 9903. According to SCImago Journal Rank (SJR), this journal is ranked 0.586. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.586 |
| 2023 | 0.579 |
| 2022 | 0.622 |
| 2021 | 0.688 |
| 2020 | 0.959 |
| 2019 | 0.874 |
| 2018 | 0.839 |
| 2017 | 0.826 |
| 2016 | 0.717 |
| 2015 | 0.722 |
| 2014 | 0.815 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 9903 |
| 2023 | 9304 |
| 2022 | 8223 |
| 2021 | 7013 |
| 2020 | 4647 |
| 2019 | 5266 |
| 2018 | 5539 |
| 2017 | 5611 |
| 2016 | 6585 |
| 2015 | 6598 |
| 2014 | 5603 |
Cancer Biomarkers is published by SAGE Publications Ltd. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2005-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Biomarkers is Cancer Biomark.. This abbreviation ('Cancer Biomark.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Biomarkers latest impact IF is 1.79. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.83 (2020) and 1.79 (2024), respectively, in the last 11 years. Moreover, its average IS is 2.6 in the previous 11 years.
The Cancer Biomarkers has an SJR (SCImago Journal Rank) of 0.586, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.959 in 2020 and the lowest being 0.579 in 2023. Furthermore, the average SJR of the Cancer Biomarkers over the previous 11-year period stands at 2.6.
The latest h-index of the Cancer Biomarkers is 57.
The Cancer Biomarkers is published by the SAGE Publications Ltd, with its country of publication being the Netherlands.
The Cancer Biomarkers is currently ranked 9903 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4647 in 2020 and its lowest position of 9903 in 2024.
The standard ISO4 abbreviation for the Cancer Biomarkers is Cancer Biomark..
Cancer Biomarkers is classified as a journal that the SAGE Publications Ltd publishes.
The Cancer Biomarkers encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Biomarkers is assigned the following International Standard Serial Numbers (ISSN): 15740153, 18758592.
The best quartile for the Cancer Biomarkers is Q2 (2024).
The Cancer Biomarkers coverage history can be summarized as follows: 2005-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 30965 | Georg Thieme Verlag | 44 | 0.46 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Biological Procedures Online | journal | 5232 | BioMed Central Ltd | 51 | 4.00 |
| Journal of Imaging Science and Technology | journal | 22021 | Society for Imaging Science and Technology | 45 | 0.61 |
| European Journal of Cancer, Supplement | journal | 13149 | Elsevier Ltd | 30 | 0.00 |
| Poljoprivreda | journal | 17375 | Faculty of Agriculture in Osijek | 16 | 1.31 |
| Transboundary and Emerging Diseases | journal | 5531 | John Wiley and Sons Ltd | 92 | 3.26 |
| Contemporanea | journal | 29075 | Societa Editrice Il Mulino | 7 | 0.12 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.79 |
| 2023 | 2.13 |
| 2022 | 2.86 |
| 2021 | 3.55 |
| 2020 | 3.83 |
| 2019 | 3.08 |
| 2018 | 2.70 |
| 2017 | 2.54 |
| 2016 | 2.40 |
| 2015 | 1.89 |
| 2014 | 1.87 |
